Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Procept Biorobotics Corp before investing.

In this article, we go over a few key elements for understanding Procept Biorobotics Corp’s stock price such as:

• Procept Biorobotics Corp’s current stock price and volume
• Why Procept Biorobotics Corp’s stock price changed recently
• Upgrades and downgrades for PRCT from analysts
• PRCT’s stock price momentum as measured by its relative strength

About Procept Biorobotics Corp (PRCT)

Before we jump into Procept Biorobotics Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

PROCEPT BioRobotics Corporation is a surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures and sells the AquaBeam Robotic System, which is an image-guided surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). The AquaBeam Robotic System employs a single-use disposable handpiece to deliver the Company’s proprietary Aquablation therapy, which combines real-time, multi-dimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The Company designed Aquablation therapy to deliver effective, safe and durable outcomes for males suffering from lower urinary tract symptoms, (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Want to learn more about Procept Biorobotics Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Procept Biorobotics Corp.

Procept Biorobotics Corp’s Stock Price as of Market Close

As of August 27, 2024, 4:00 PM, CST, Procept Biorobotics Corp’s stock price was $81.46.

Procept Biorobotics Corp is up 4.41% from its previous closing price of $78.02.

During the last market session, Procept Biorobotics Corp’s stock traded between $77.82 and $80.91. Currently, there are 51.62 million shares of Procept Biorobotics Corp stock available for purchase.

Unfortunately, Procept Biorobotics Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Procept Biorobotics Corp Stock Price History

Procept Biorobotics Corp’s (PRCT) price is currently up 28.65% so far this month.

During the month of August, Procept Biorobotics Corp’s stock price has reached a high of $85.81 and a low of $54.02.

Over the last year, Procept Biorobotics Corp has hit prices as high as $85.81 and as low as $24.83. Year to date, Procept Biorobotics Corp’s stock is up 96.1%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Procept Biorobotics Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 26, 2024, there were 4 analysts who downgraded Procept Biorobotics Corp’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Procept Biorobotics Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Procept Biorobotics Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Procept Biorobotics Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Procept Biorobotics Corp (PRCT) by visiting AAII Stock Evaluator.

Relative Price Strength of Procept Biorobotics Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 26, 2024, Procept Biorobotics Corp has a weighted four-quarter relative price strength of 17.96%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how Procept Biorobotics Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Procept Biorobotics Corp Stock Price: Bottom Line

As of August 27, 2024, Procept Biorobotics Corp’s stock price is $81.46, which is up 4.41% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Procept Biorobotics Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.